ArticleSAGE open medicine2025

A multicenter, postmarketing surveillance of elobixibat in patients with chronic constipation in Japan: A final analysis report.

Atsushi Nakajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.